Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2005-12-02
Original market date: See footnote 1
2005-12-02
Product name:
AVONEX
Description:
PREFILLED SYRINGE, PREFILLED AUTOINJECTOR
DIN:
02269201
Product Monograph/Veterinary Labelling:
Date:
2022-08-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BIOGEN CANADA INC
3300 Bloor Street West, West Tower, Suite 1200
Toronto
Ontario
Canada
M8X 2X2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription , Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
92:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L03AB07 INTERFERON BETA-1A
Active ingredient group (AIG) number:See footnote5
0131806004
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| INTERFERON BETA-1A | 30 MCG / 0.5 ML |